Endothelium-derived relaxing factor: Discovery, early studies, and identifcation as nitric oxide (Nobel lecture)

Angewandte Chemie - International Edition

Volumn 38, Issue 13-14, 1999, Pages 1870-1880

  Furchgott, Robert F ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Enzymes; Neurotransmitters; Nitric oxide; Nobel lecture; Signal transduction

Indexed keywords

ACETYLCHOLINE; CATECHOLAMINE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HISTAMINE; NITRIC OXIDE; SODIUM NITRITE;

ANIMAL TISSUE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; NEUROTRANSMISSION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 0033549578     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-3773(19990712)38:13/14<1870::aid-anie1870>3.0.co;2-8     Document Type: Review

References (62)

1. "Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs": R. F. Furchgott, S. Bhadrakom, J. Pharmacol. Exp. Ther. 1953, 108, 129-143.
2. "Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors": R. F. Furchgott, J. Pharmacol. Exp. Ther. 1954, 111, 265-284.
3. "The discovery of endothelium-dependent relaxation": R. F. Furchgott, Circulation, Suppl. 1993, 87 (V), V3-V8.
4. "The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by ACh": R. F. Furchgott, J. V. Zawadzki, Nature 1980, 288, 373-376.
5. "The role of endothelial cells in the relaxation of isolated arteries by bradykinin": P. D. Cherry, R. F. Furchgott, J. V. Zawadzki, D. Jothianandan, Proc. Nat. Acad. Sci. USA 1982, 79, 2106-2110.
6. "Dilator and constrictor effects of acetylcholine on isolated rabbit aortic chains": R. W. Jelliffe, J. Pharmacol. Exp. Ther. 1962, 135, 349-353.
7. "Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle": P. M. Vanhoutte, Circ. Res. 1974, 34, 317-326.
8. "The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog": N. Toda, J. Pharmacol. Exp. Ther. 1974, 193, 376-384.
9. "Inhibition of adrenergic neurotransmission by parasympathomimetics in the rabbit ear artery": O. S. Steinsland, R. F. Furchgott, S. M. Kirpekar, J. Pharmacol. Exp. Ther. 1973, 184, 346-356.
10. "Endothelium-derived relaxing factor: some old and new findings": R. F. Furchgott, D. Jothianandan, A. D. Freay in Nitric Oxide from L-Arginine: A Bioregulatory System (Eds.: S. Moncada, E. A. Higgs), Elsevier, Amsterdam, 1990, pp. 5-17,
11. "Endothelium-derived relaxing and contracting factors": R. F. Furchgott, P. M. Vanhoutte, FASEB J. 1989, 3, 2007-2018.
12. "The 1989 Ulf von Euler Lecture: Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor": R. F. Furchgott, Acta Physiol. Scand. 1990, 139, 257-270.
13. "The requirement for endothelial cells in the relaxation of arteries by ACh and some other vasodilators": R. F. Furchgott, Trends Pharmacol. Sci. 1981, 2, 173-176.
14. "Role of endothelium in the vasodilator responses of rat theriac aorta to histamine": J. Van de Voorde, I. Leusen, Eur. J. Pharmacol. 1983, 87, 113-120.
15. "Role of endothelium in the responses of vascular smooth muscle": R. F. Furchgott, Circ. Res. 1983, 53, 557-573.
16. "Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin": T. M. Cocks, J. A. Angus, Nature 1983, 305, 627-630.
17. "5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries": R. A. Cohen, J. T. Shepherd, P. M. Vanhoutte, Am. J. Physiol. 1983, 245, H1077-H1080.
18. "Role of endothelium in the vasodilator response to ACh": R. F. Furchgott, J. V. Zawadzki, P. D. Cherry in Vasodilatation (Eds.: P. Vanhoutte, I. Leusen), Raven Press, New York, 1981, pp. 49-66.
19. "Regulation of adenosine cyclic 3′,5′-monophosphate levels and contractility in bovine tracheal smooth muscle": S. Katsuki, F. Murad, Mol. Pharmacol. 1977, 13, 330-341.
20. "Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets": E. Böhme, H. Graf, G. Schultz, Adv. Cyclic Nucleotide Res. 1978, 9, 131-143.
21. Review: "Guanylate cyclase activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin": F. Murad, C. K. Mittal, W. P. Arnold, S. Katsuki, H. Kimura, Adv. Cyclic Nucleotide Res. 1978, 9, 145-158.
22. Review: "Properties and regulation of guanylate cyclase and some proposed functions of cyclic GMP": F. Murad, W. P. Arnold, C. K. Mittal, J. M. Braughler, Adv. Cyclic Nucleotide Res. 1979, 11, 175-204.
23. "Stimulation of platelet guanylate cyclase by unsaturated fatty acid peroxides": H. Hidaka, T. Asano, Proc. Natl. Acad. Sci. USA 1977, 74, 3657-3661.
24. "Redox modulation of splenic cell soluble guanylate cyclase activity: Activation by hydrophilic and hydrophobic antioxidants represented by ascorbic and dehydroascorbic acids, fatty acid hydroperoxides, and prostaglandin endoperoxides": N. D. Goldberg, G. Graff, M. K. Haddox, J. H. Stephenson, D. B. Glass, M. E. Moser, Adv. Cyclic Nucleotide Res. 1978, 9, 101-130.
25. "Agonist-induced endothelium-dependent relaxations in rat thoracic aorta may be mediated through cGMP": R. M. Rapoport, F. Murad, Circ. Res. 1983, 52, 352-357.
26. "Possible role for cyclic GMP in endothelium-dependent relaxation of rabbit aorta by ACh. Comparison with nitroglycerin": J. Diamond, E. B. Chu, Res. Commun. Chem. Pathol. Pharmacol. 1983, 41, 369-381.
27. "Endothelial cells as mediators of vasodilation of arteries": R. F. Furchgott, P. D. Cherry, J. V. Zawadzki, D. Jothianandan, J. Cardiovasc. Pharmacol. 1984, 6 (suppl. 2), S336-S344.
28. "Endothelium-induced relaxation by ACh associated with larger rises in cyclic GMP in coronary arterial strips": S. Holzmann, J. Cyclic Nucleotide Res. 1982, 8, 409-419.
29. "Association between cyclic GMP accumulation and ACh-elicited relaxation of bovine intrapulmonary artery": L. J. Ignarro, T. M. Burke, K. S. Wood, M. S. Wolin, P. J. Kadowitz, J. Pharmacol. Exp. Ther. 1984, 228, 682-690.
30. "Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and carcinogenic nitrosoamine": C. A. Gruetter, B. K. Barry, D. B. McNamara, D. Y. Gruetter, P. J. Kadowitz, L. J. Ignarro, J. Cyclic Nucleotide Res. 1979, 5, 211-214.
31. "Oxyhaemoglobin blocks nonadrenergic inhibition in the bovine retractor penis muscle": A. Bowman, J. S. Gillespie, D. Pollock, Eur. J. Pharmacol. 1982, 85, 221-224.
32. "Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin": C. A. Gruetter, D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, E. F. Ignarro, J. Pharmacol. Exp. Ther. 1981, 219, 181-186.
33. "Some physical and chemical properties of the smooth muscle inhibitory factor in extracts of the bovine retractor penis muscle": J. S. Gillespie, J. C. Hunter, W. Martin, J. Physiol. 1981, 315, 111-125.
34. "Actions on the cardiovascular system of an inhibitory material extracted from the bovine retractor penis": A. Bowman, J. S. Gillespie, W. Martin, Br. J. Pharmacol. 1981, 72, 365-372.
35. "Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta": W. Martin, G. M. Villani, D. Jothianandan, R. F. Furchgolt, J. Pharmacol. Exp. Ther. 1985, 232, 708-716.
36. "Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor (EDRF)": W. Martin, R. F. Furchgott, G. M. Villani, D. Jothianandan, J. Pharmacol. Exp. Ther. 1986, 237, 529-538.
37. "Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins": W. Martin, G. M. Villani, D. Jothianandan, R. F. Furchgott, J. Pharmacol. Exp. Ther. 1985, 233, 679-685.
38. "Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor (EDRF)": W. Martin, R. F. Furchgott, G. M. Villani, D. Jothianandan, J. Pharmacol. Exp. Ther. 1986, 237, 539-547.
39. "Oxidation of nitrogen oxides by bound dioxygen in hemoproteins": M. P. Doyle, J. W. Hoekstra, J. Inorg. Biochem. 1981, 14, 351-358.
40. See "Methylene blue inhibits vasodilation of skeletal muscle arterioles to ACh and nitric oxide via the extracellular generation of superoxide anion": M. S. Wolin, P. D. Cherry, J. M. Rodenburg, E. J. Messina, G. Kaley, J. Pharmacol. Exp. Ther. 1990, 254, 872-876.
41. "Species-dependent differences in the value of endothelium-derived vascular relaxing factor": U. Förstermann, G. Trogisch, R. Busse, Eur. J. Pharmacol. 1984, 106, 639-643.
42. "The nature of the endothelium-derived vascular relaxant factor": T. M. Griffith, D. H. Edwards, A. C. Newby, M. J. Lewis, A. C. Newby, A. H. Henderson, Nature 1984, 305, 645-647.
43. "Bioassay of endothelium-derived relaxing factor": G. M. Rubanyi, R. R. Lorenz, P. M. Vanhoutte, Am. J. Physiol. 1985, 215, H1077-H1080.
44. "Additional evidence that endothelium-derived relaxing factor is nitric oxide": M. T. Khan, R. F. Furchgott in Pharmacology (Eds.: M. J. Rand, C. Raper), Elsevier, Amsterdam, 1987, pp. 341-344.
45. "Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture": T. M. Cocks, J. A. Angus, J. H. Campbell, G. R. Campbell. J. Cell Physiol. 1985, 123, 310-320.
46. "Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor": P. J. Gryglewski, R. M. Palmer, S. A. Moncada, Nature 1986, 320, 454-456.
47. "Superoxide anions and hyperoxia inactive endothelium-derived relaxing factor": G. M. Rubanyi, P. M. Vanhoutte, Am. J. Physiol. 1986, 250, H822-H827.
48. "Mechanism of action of some inhibitors of endothelium-derived relaxing factor": S. Moncada, R. M. J. Palmer, R. J. Gryglewski, Proc. Nail. Acad. Sci. USA 1986, 83, 9164-9168.
49. "Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition": J. Holtz, U. Förstermann, U. Pohl, M. Giesler, E. Bassenge, J. Cardiovasc. Pharmacol. 1984, 6, 1161-1169.
50. "Flow-induced release of endothelium-derived relaxing factor": G. M. Rubanyi, J. C. Romero, P. M. Vanhoutte, Am. J. Physiol. 1986, 250, H1145-H1149.
51. "Mediation of flow-dependent arterial dilation by endothelial cells": L. Kaiser, H. V. Sparks, Jr., Circ. Shock, 1986, 18, 109-114.
52. "Crucial role of endothelium in the vasodilator response to increased flow in vivo": U Pohl, J. Holtz, R. Busse, E. Bassenge Hypertension, 1986, 8, 37-44.
53. "Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle": A. Bowman, A. H. Drummond, Br. J. Pharmacol. 1984, 81, 665-674.
54. "Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide": R. F. Furchgott, in Vasodilatation: Vascular Smooth Muscle, Peptides, and Endothelium (Ed.: P. M. Vanhoutte), Raven Press, New York, 1988, pp. 401-414.
55. "Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide": J. S. Beckman, T. W. Beckman, J. Chen, P. A. Marshall, B. A. Freeman, Proc. Natl. Acad. Sci. USA 1990, 87, 1620-1624.
56. "Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical": L. J. Ignarro, R. E. Byrns, K. S. Wood in Vasodilatation: Vascular Smooth Muscle, Peptides, and Endothelium (Ed.: P. M. Vanhoutte), Raven press, New York, 1988, pp. 427-435.
57. "Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide": L. J. Ignarro, G. M. Buga, K. S. Wood, R. E. Byrns, G. Chaudhuri, Proc. Natl. Acad. Sci. USA 1987, 84, 9265-9269.
58. "Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor": R. M. J. Palmer, A. G. Ferrige, S. Moncada, Nature 1987, 327, 524-526.
59. "Vascular endothelial cells synthesize nitric oxide from L-arginine": R. M. J. Palmer, D.S. Ashton, S. Moncada, Nature 1988, 333, 664-666.
60. For a review of these apparent or real inconsistencies, see "Comparison of properties of nitric oxide and endothelium-derived relaxing factor: Some cautionary findings": R. F. Furchgott, M. T. Khan, D. Jothianandan in Endothelium-derived Relaxing Factors (Eds.: G. M. Rubanyi, P. M. Vanhoutte), Karger. Basel, 1990, pp. 8-21.
61. Review: "Endothelium-dependent hyperpolarization: a role in the control of vascular tone": C. J. Garland, F. Plane, B. K. Kemp, T. M. Cocks, Trends Pharmacol. Sci. 1995, 16, 23-30.
62. "The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide": R. F. Furchgott, J. Am. Med. Assoc. 1996, 276, 1186-1188.